share_log

Eli Lilly and Co | 3: Initial statement of beneficial ownership of securities-Officer Brooks Gordon J.

Eli Lilly and Co | 3: Initial statement of beneficial ownership of securities-Officer Brooks Gordon J.

礼来 | 3：首次持股声明-高管 Brooks Gordon J.
美股sec公告 ·  07/19 16:21
Moomoo AI 已提取核心信息
Gordon J. Brooks, the Interim CFO and Group VP of Eli Lilly and Co, filed an Initial Statement of Beneficial Ownership with the SEC on July 15, 2024. The filing, required under Section 16(a) of the Securities Exchange Act of 1934, disclosed Brooks' ownership of 12,403 direct shares and 3,694 indirect shares through a 401(k). Additionally, Brooks holds derivative securities in the form of Restricted Stock Units (RSUs) with various expiration dates ranging from November 1, 2024, to February 16, 2027, totaling 8,221 RSUs, and 741 shares of Phantom Stock. The RSUs represent a contingent right to receive Eli Lilly common stock, while the Phantom Stock reflects benefits under the company's excess savings plan, payable in cash upon retirement or termination of service. The form was signed on behalf of Brooks by Jonathan Groff, indicating Brooks' compliance with the SEC's reporting requirements.
Gordon J. Brooks, the Interim CFO and Group VP of Eli Lilly and Co, filed an Initial Statement of Beneficial Ownership with the SEC on July 15, 2024. The filing, required under Section 16(a) of the Securities Exchange Act of 1934, disclosed Brooks' ownership of 12,403 direct shares and 3,694 indirect shares through a 401(k). Additionally, Brooks holds derivative securities in the form of Restricted Stock Units (RSUs) with various expiration dates ranging from November 1, 2024, to February 16, 2027, totaling 8,221 RSUs, and 741 shares of Phantom Stock. The RSUs represent a contingent right to receive Eli Lilly common stock, while the Phantom Stock reflects benefits under the company's excess savings plan, payable in cash upon retirement or termination of service. The form was signed on behalf of Brooks by Jonathan Groff, indicating Brooks' compliance with the SEC's reporting requirements.
Eli Lilly and Co公司代理首席财务官，集团副总裁Gordon J. Brooks于2024年7月15日向SEC提出了一份初始的有益所有权声明。根据1934年证券交易法第16(a)条的规定，申报披露了Brooks持有的12,403股直接股份和通过401(k)持有的3,694股间接股份。此外，Brooks持有各种到期日从2024年11月1日至2027年2月16日期间的限制性股票单位（RSUs）共计8,221股，以及741股幻影股票。RSUs代表有权获得Eli Lilly股票的权利，而幻影股票则反映了公司退休或终止服务时的 excess savings plan 的利益，可用现金支付。该表格是由Jonathan Groff代表Brooks签署的，表明Brooks遵守了SEC的申报要求。
Eli Lilly and Co公司代理首席财务官，集团副总裁Gordon J. Brooks于2024年7月15日向SEC提出了一份初始的有益所有权声明。根据1934年证券交易法第16(a)条的规定，申报披露了Brooks持有的12,403股直接股份和通过401(k)持有的3,694股间接股份。此外，Brooks持有各种到期日从2024年11月1日至2027年2月16日期间的限制性股票单位（RSUs）共计8,221股，以及741股幻影股票。RSUs代表有权获得Eli Lilly股票的权利，而幻影股票则反映了公司退休或终止服务时的 excess savings plan 的利益，可用现金支付。该表格是由Jonathan Groff代表Brooks签署的，表明Brooks遵守了SEC的申报要求。
有用
没用

该公告为独立文件：

独立文件1  查看翻译

独立文件2  查看翻译

声明：本内容仅用作提供资讯及教育之目的，不构成对任何特定投资或投资策略的推荐或认可。 更多信息